Condition: Borderline Resectable Pancreatic Ductal Adenocarcinoma · Resectable Pancreatic Ductal Adenocarcinoma · Stage I Pancreatic Cancer AJCC v8 · Sponsor: Emory University
This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.
This description comes directly from the study's public registry record.
Mihir M. Shah, MD, FACS, FSSO · 404-778-3307 · mihir.m.shah@emory.edu
Always discuss trial participation with your own doctor first.
| Emory University Hospital/Winship Cancer Institute | Atlanta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06595160